Neurosteer - Advancing the Century-Old EEG into the 21st Century
Overview
Neurosteer is a company in the neurotech sector based in New York, NY. It has developed a medical-grade wearable device and a cloud-based system for real-time monitoring and assessment of brain activity. The company focuses on delivering objective biomarkers to identify the early onset of neurological disorders such as Parkinson’s, Alzheimer’s, dementia, and epilepsy. Neurosteer's solution includes an adhesive forehead strip connected to a pocket-sized device that wirelessly transmits sensor data to the cloud for proprietary signal processing. Advanced algorithms decompose the single EEG channel into over 100 individual components for real-time analysis, which is displayed on a web-based dashboard. This technology enables more affordable screening, continuous patient monitoring, and optimized neurostimulation and drug selection, ultimately improving neurological treatment and the outcomes of clinical trials.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2015
- Followers
- 1,464
- Specialties
- Digital Health, Neurological Disorders, and Neurodegenerative Disorders
- Locations
- New York New York, NY 10280, US
Funding
Total rounds: 3
Last round: Seed, Jul 1, 2019
Last round amount: US$ 4.5M